Iatrogenic Creutzfeldt-Jakob disease with Amyloid-beta pathology: an international study
Ignazio Cali, Mark L Cohen, Stephane Haik, Piero Parchi, Giorgio Giaccone, Steven J Collins, Diane Kofskey, Han Wang, Catriona A McLean, Jean-Philippe Brandel, Nicolas Privat, Veronique Sazdovitch, Charles Duyckaerts, Tetsuyuki Kitamoto, Ermias D Belay, Ryan A Maddox, Fabrizio Tagliavini, Maurizio Pocchiari, Ellen Leschek, Brian S Appleby Show all
ACTA NEUROPATHOLOGICA COMMUNICATIONS | BIOMED CENTRAL LTD | Published : 2018
Awarded by CDC
Awarded by NIH
Awarded by program "Investissements 276 d'avenir"
Awarded by NHMRC
This work was supported by: CDC 000309CK14 to J.G. Safar; NIH P01AI106705, NIH 5R01NS083687 and Charles S. Britton Fund. to P. Gambetti; The Reseau National de Reference de maladies de Creutzfeldt-Jakob and the "Centre National de Reference des agents transmissibles non conventionnels" (Paris, France) are supported by Sante Publique France; Inserm 1127 has received funding from the program "Investissements 276 d'avenir" ANR-10-IAIHU-06; Italian Ministry of Health funding to F. Tagliavini; Stivison Fund for CJD Research to B.S. Appleby; The Australian National Creutzfeldt-Jakob Disease Registry is funded by the Commonwealth Department of Health and S. Collins is funded in part by a NHMRC Practitioner Fellowship (# APP1105784); Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) from MEXT to T. Kitamoto.